New insights into how genetic variants influence disease risk

FHS
July 25, 2024
6:44 am

A new study by scientists at deCODE Genetics, a subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases and other human traits.

AstraZeneca launches GLP-1 combo to treat obesity co-morbidities

Share this article AstraZeneca has announced its strategy for the cardiometabolic market, in particular for treating obesity. Credit: encierro via Shutterstock. AstraZeneca has announced its

November 14, 2023

Broader Cancer Risk With CAR-T? AI for Physician Burnout; ‘Lollipops’ ID Oral Cancer

T-cell malignancies represent a small fraction of secondary cancers in patients treated with CAR T-cell therapy. (American Society of Hematology) In an update to a

March 23, 2024

Praxis prices $150M public stock offering ahead of four topline neuro readouts in 2024

Boston-based Praxis Precision Medicines announced Thursday the pricing of a $150 million public stock offering, with an expected close date around Jan. 16. Praxis is

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.